Zonegran and Ritalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zonegran (zonisamide) and Ritalin (methylphenidate hydrochloride). Common drug interactions include kidney infection among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Zonegran and Ritalin. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.

What is Zonegran?

Zonegran has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 6,211 Zonegran users. Check the latest studies of Zonegran.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.



On Jul, 12, 2026

89 people who take Zonegran and Ritalin together, and have interactions are studied.

Zonegran and Ritalin drug interactions.

What are the common drug interactions of Zonegran and Ritalin, by gender? *:

female:

  1. Kidney infection
  2. Laceration (tearing of soft body tissue)
  3. Ligament sprain (ligament stretched)
  4. Loss of consciousness
  5. Lymphocyte count decreased
  6. Micturition urgency (urgency to pass the urine)
  7. Urinary tract infection
  8. Suicidal ideation
  9. Type 2 diabetes mellitus
  10. Dry eye (lack of adequate tears)

male:

  1. Fall
  2. Alcohol poisoning
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Glossitis (infection of tongue with soreness)
  5. Head injury
  6. Loss of consciousness
  7. Paraplegia (paralysis of the legs and lower body)
  8. Renal failure (kidney dysfunction)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Speech disorder

What are the common drug interactions of Zonegran and Ritalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abasia (inability to walk)
  2. Head lag (weak head and neck control)
  3. Muscular weakness (muscle weakness)
  4. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  5. Speech disorder
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)

10-19:

n/a

20-29:

n/a

30-39:

  1. Alcohol poisoning
  2. Arthralgia (joint pain)
  3. Back injury
  4. Back pain
  5. Cervical vertebral fracture
  6. Concussion (short loss of normal brain function in response to a head injury)
  7. Confusional state
  8. Cough
  9. Drug specific antibody present
  10. Dysphagia (a condition in which swallowing is difficult or painful)

40-49:

  1. Mood altered (changes in mood)
  2. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  3. Muscular weakness (muscle weakness)
  4. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  5. Paranasal cyst (cyst near the nose)
  6. Suicidal ideation
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Temperature intolerance (inability to go in temperature)
  9. Therapeutic response unexpected
  10. Type 2 diabetes mellitus

50-59:

  1. Nephrolithiasis (calculi in the kidneys)
  2. Chronic kidney disease
  3. Hospitalisation
  4. Hypokalaemia (low potassium)
  5. Infection
  6. Hypersensitivity
  7. Hypotension (abnormally low blood pressure)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Respiratory rate decreased (less breathing rate/min)
  10. Unresponsive to stimuli

60+:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Lower respiratory tract infection
  4. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  5. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  6. Neck pain
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Nephropathy (damage to or disease of a kidney)
  9. Pain in extremity
  10. Peripheral swelling

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 56 people, 62.92%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 39 people, 43.82%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 11.24%
  4. Pain: 9 people, 10.11%
  5. Migraine (headache): 9 people, 10.11%
  6. Stress And Anxiety: 7 people, 7.87%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 6.74%
  8. High Blood Pressure: 5 people, 5.62%
  9. Drowsiness: 5 people, 5.62%

* Approximation only. Some reports may have incomplete information.

Do you take Zonegran and Ritalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zonegran and Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zonegran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zonegran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ritalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on zonisamide and methylphenidate hydrochloride (the active ingredients of Zonegran and Ritalin, respectively), and Zonegran and Ritalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: